OrbiMed Capital GP V LLC, Director, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 285,312 shares at $3.51 ($1.0M) on 2019-08-06, disclosed to the SEC on 2019-08-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.51 | 142,656 | $501K | 50.0% |
| 2 | $3.51 | 142,656 | $501K | 50.0% |
| Total | $3.51 avg | 285,312 | $1.0M | 100% |
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |